Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Hila Barak"'
Autor:
Arbelle, Assaf, Doveh, Sivan, Alfassy, Amit, Shtok, Joseph, Lev, Guy, Schwartz, Eli, Kuehne, Hilde, Levi, Hila Barak, Sattigeri, Prasanna, Panda, Rameswar, Chen, Chun-Fu, Bronstein, Alex, Saenko, Kate, Ullman, Shimon, Giryes, Raja, Feris, Rogerio, Karlinsky, Leonid
Nowadays, there is an abundance of data involving images and surrounding free-form text weakly corresponding to those images. Weakly Supervised phrase-Grounding (WSG) deals with the task of using this data to learn to localize (or to ground) arbitrar
Externí odkaz:
http://arxiv.org/abs/2104.09829
Autor:
Assaf Arbelle, Sivan Doveh, Amit Alfassy, Joseph Shtok, Guy Lev, Eli Schwartz, Hilde Kuehne, Hila Barak Levi, Prasanna Sattigeri, Rameswar Panda, Chun-Fu Chen, Alex Bronstein, Kate Saenko, Shimon Ullman, Raja Giryes, Rogerio Feris, Leonid Karlinsky
Publikováno v:
2021 IEEE/CVF International Conference on Computer Vision (ICCV)
International Conference on Computer Vision (ICCV)
International Conference on Computer Vision (ICCV)
Nowadays, there is an abundance of data involving images and surrounding free-form text weakly corresponding to those images. Weakly Supervised phrase-Grounding (WSG) deals with the task of using this data to learn to localize (or to ground) arbitrar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6d49b50c08e130c45741ac4c1dae8514
Autor:
A. Alistar, A. Retiere, Kyu-Pyo Kim, Charles D. Lopez, Ben George, Xiaosong Zhang, Vincent Chung, Hedy L. Kindler, Colby S. Shemesh, D-Y. Oh, Hila Barak, Volker Teichgräber, Bo Ci, Janet Lau, Simon Allen
Publikováno v:
Annals of Oncology. 31:S218
Autor:
Anne-Cecile Retiere, Jill Lacy, Do-Youn Oh, Andrew H. Ko, Jens T. Siveke, N. Al-Sakaff, Colby S. Shemesh, Simon Allen, Jaffer A. Ajani, Kyu-Pyo Kim, Charles D. Lopez, Janet Lau, Hyun Cheol Chung, Maria Alsina, Xiaosong Zhang, Yung-Jue Bang, Hila Barak, Eileen M. O'Reilly, Jeeyun Lee, S. Li
Publikováno v:
Journal of Clinical Oncology. 38:4540-4540
4540 Background: The MORPHEUS platform consists of multiple, global, open-label, randomized Phase Ib/II trials designed to identify early efficacy signals and safety of treatment (tx) combinations across cancers. Within MORPHEUS, atezo (anti–PD-L1)
Autor:
Do-Youn Oh, Jaffer A. Ajani, Yung-Jue Bang, Hyun Cheol Chung, Jill Lacy, Jeeyun Lee, Teresa Macarulla, Gulam Abbas Manji, Eileen Mary O'Reilly, Simon Allen, Nedal Jaffer Abdulla Al-Sakaff, Hila Barak, Jilpa Patel, Jan Peter Pintoffl, Colby Shemesh, Wei Zhang, Xiaosong Zhang, Ian Chau
Publikováno v:
Journal of Clinical Oncology. 38:712-712
712 Background: The MORPHEUS platform comprises multiple Ph Ib/II trials to identify early efficacy signals and safety of treatment (tx) combinations across cancers. Due to the immune-mediated effects of BL-8040, a high-affinity antagonist for CXCR4,
Autor:
Jilpa Bhupendra Patel, Marwan Fakih, Edward Cha, Hyun Cheol Chung, Andrew H. Ko, Kun-Huei Yeh, Neil H. Segal, Kyu-Pyo Kim, N. Al-Sakaff, Jun Wang, Do-Youn Oh, Conrad Bleul, Osama E. Rahma, Jayesh Desai, Jeeyun Lee, Xiaosong Zhang, Jeremy S. Kortmansky, S. Li, Hila Barak, Maria Alsina
Publikováno v:
Journal of Clinical Oncology. 37:TPS467-TPS467
TPS467 Background: CIT has significant survival benefits across multiple tumor types, but durable response is experienced by only subsets of patients (pts). To extend clinical benefit to more pts, efficacious CIT combinations (combos) targeting multi
Autor:
Rémi Salomon, Hila Barak, Christine Bole-Feysot, Shuang Chen, Corinne Antignac, Patrick Nitschké, David M. Ornitz, Sung Ho Huh, Jelena Martinovic, Cécile Jeanpierre, Mélanie Parisot, Raphael Kopan
Publikováno v:
Developmental Cell. 22(6):1191-1207
SummaryThe identity of niche signals necessary to maintain embryonic nephron progenitors is unclear. Here we provide evidence that Fgf20 and Fgf9, expressed in the niche, and Fgf9, secreted from the adjacent ureteric bud, are necessary and sufficient
Autor:
S.L. McCune, I. Chau, Teresa Macarulla, Ben Solomon, Melissa Lynne Johnson, Sami Mahrus, Peter Schmid, Guillem Argiles, Georg Martin Haag, K. Dimick, Xian He, Osama E. Rahma, Conrad Bleul, G.A. Vidal, Edward Cha, A. Drakaki, Hussein A. Abdullah, Denise A. Yardley, Pakeeza Sayyed, Hila Barak
Publikováno v:
Annals of Oncology. 29:viii439-viii440
Autor:
Salah-Eddin Al-Batran, Eileen M. O'Reilly, Do-Youn Oh, Edward Cha, Xiaosong Zhang, Hila Barak, Kyu-Pyo Kim, Antoine Hollebecque, Osama E. Rahma, Gulam Abbas Manji, Syma Iqbal, Pakeeza Sayyed, Jill Lacy, Jun Wang, Tanios Bekaii-Saab, Antonia Kwan, Xian He, Hyun Cheol Chung, Harry H. Yoon
Publikováno v:
Journal of Clinical Oncology. 36:TPS4134-TPS4134
TPS4134Background: Multiple cancers have been treated successfully with CIT; nonetheless, only subsets of pts experience durable response with CIT monotherapy. CIT combinations may therefore be nee...
Autor:
Justin F. Gainor, Mark M. Awad, Conrad Bleul, Melissa Lynne Johnson, Hans-Joachim Helms, Benjamin Solomon, Hila Barak, Bhumsuk Keam, Edward Cha, Chen Huang, Marcella Fassò, Sarah B. Goldberg, Dae Ho Lee, Naiyer A. Rizvi, Byoung Chul Cho
Publikováno v:
Journal of Clinical Oncology. 36:TPS9105-TPS9105
TPS9105Background: CIT has demonstrated a significant survival benefit in multiple cancers. Despite this, only subsets of pts experience durable response with CIT monotherapy. Thus, CIT combination...